230 related articles for article (PubMed ID: 23510467)
1. Epigenetically induced changes in nuclear textural patterns and gelatinase expression in human fibrosarcoma cells.
Poplineau M; Doliwa C; Schnekenburger M; Antonicelli F; Diederich M; Trussardi-Régnier A; Dufer J
Cell Prolif; 2013 Apr; 46(2):127-36. PubMed ID: 23510467
[TBL] [Abstract][Full Text] [Related]
2. The DNA hypomethylating agent, 5-aza-2'-deoxycytidine, enhances tumor cell invasion through a transcription-dependent modulation of MMP-1 expression in human fibrosarcoma cells.
Poplineau M; Schnekenburger M; Dufer J; Kosciarz A; Brassart-Pasco S; Antonicelli F; Diederich M; Trussardi-Régnier A
Mol Carcinog; 2015 Jan; 54(1):24-34. PubMed ID: 24038389
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of proMMP-1 expression in the HT1080 human fibrosarcoma cell line.
Poplineau M; Dufer J; Antonicelli F; Trussardi-Regnier A
Int J Oncol; 2011 Jun; 38(6):1713-8. PubMed ID: 21424117
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
Meng F; Sun G; Zhong M; Yu Y; Brewer MA
Int J Oncol; 2013 Aug; 43(2):495-502. PubMed ID: 23709006
[TBL] [Abstract][Full Text] [Related]
5. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
6. HSPC117 is regulated by epigenetic modification and is involved in the migration of JEG-3 cells.
Ma H; Qi MY; Zhang X; Zhang YL; Wang L; Li ZQ; Fu B; Wang WT; Liu D
Int J Mol Sci; 2014 Jun; 15(6):10936-49. PubMed ID: 24941254
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention.
Iliopoulos D; Malizos KN; Tsezou A
Ann Rheum Dis; 2007 Dec; 66(12):1616-21. PubMed ID: 17502362
[TBL] [Abstract][Full Text] [Related]
8. Effects of the histone deacetylase inhibitor trichostatin A on nuclear texture and c-jun gene expression in drug-sensitive and drug-resistant human H69 lung carcinoma cells.
El-Khoury V; Gomez D; Liautaud-Roger F; Trussardi-Régnier A; Dufer J
Cytometry A; 2004 Dec; 62(2):109-17. PubMed ID: 15517561
[TBL] [Abstract][Full Text] [Related]
9. 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.
Scott SA; Dong WF; Ichinohasama R; Hirsch C; Sheridan D; Sanche SE; Geyer CR; Decoteau JF
Leuk Res; 2006 Jan; 30(1):69-76. PubMed ID: 16043219
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression.
Claus R; Fliegauf M; Stock M; Duque JA; Kolanczyk M; Lübbert M
J Leukoc Biol; 2006 Dec; 80(6):1462-72. PubMed ID: 17000900
[TBL] [Abstract][Full Text] [Related]
11. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.
Zhang YW; Staal B; Dykema KJ; Furge KA; Vande Woude GF
PLoS One; 2012; 7(6):e38955. PubMed ID: 22701735
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells.
Shaker S; Bernstein M; Momparler LF; Momparler RL
Leuk Res; 2003 May; 27(5):437-44. PubMed ID: 12620295
[TBL] [Abstract][Full Text] [Related]
13. Treatment of nuclear-donor cells or cloned zygotes with chromatin-modifying agents increases histone acetylation but does not improve full-term development of cloned cattle.
Sangalli JR; De Bem TH; Perecin F; Chiaratti MR; Oliveira Lde J; de Araújo RR; Valim Pimentel JR; Smith LC; Meirelles FV
Cell Reprogram; 2012 Jun; 14(3):235-47. PubMed ID: 22468998
[TBL] [Abstract][Full Text] [Related]
14. Effect of trichostatin A and 5-Aza-2'-deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells.
Kong Q; Wu M; Wang Z; Zhang X; Li L; Liu X; Mu Y; Liu Z
Mol Cell Biochem; 2011 Sep; 355(1-2):157-65. PubMed ID: 21541675
[TBL] [Abstract][Full Text] [Related]
15. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
David GL; Yegnasubramanian S; Kumar A; Marchi VL; De Marzo AM; Lin X; Nelson WG
Cancer Biol Ther; 2004 Jun; 3(6):540-8. PubMed ID: 15034303
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines.
Yatouji S; El-Khoury V; Trentesaux C; Trussardi-Regnier A; Benabid R; Bontems F; Dufer J
Int J Oncol; 2007 Apr; 30(4):1003-9. PubMed ID: 17332941
[TBL] [Abstract][Full Text] [Related]
17. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
18. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.
Mostovich LA; Prudnikova TY; Kondratov AG; Gubanova NV; Kharchenko OA; Kutsenko OS; Vavilov PV; Haraldson K; Kashuba VI; Ernberg I; Zabarovsky ER; Grigorieva EV
Epigenetics; 2012 Aug; 7(8):930-9. PubMed ID: 22805760
[TBL] [Abstract][Full Text] [Related]
19. 5-Azacytidine regulates matrix metalloproteinase-9 expression, and the migration and invasion of human fibrosarcoma HT1080 cells via PI3-kinase and ERK1/2 pathways.
Yu SM; Kim SJ
Int J Oncol; 2016 Sep; 49(3):1241-7. PubMed ID: 27573026
[TBL] [Abstract][Full Text] [Related]
20. Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells.
Shim JS; Kim DH; Kwon HJ
Oncogene; 2004 Mar; 23(9):1704-11. PubMed ID: 14661058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
